We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
VEGF165b antibody
Vascular permeability factor (VPF)
Isoform VEGF165B, VEGF165b
Gene name: VEGFA, VEGF
Isoform VEGF165B, VEGF165b
Gene name: VEGFA, VEGF
As low as
$323.40
In stock
Ref
00051058
Isoform VEGF165b binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
| ID Covalab | pab0929-P |
|---|---|
| Product type | Primary antibodies |
| Clonality | Polyclonal antibody |
| Raised in | Rabbit |
| Immunogen | Synthetic peptide derived from N terminal part of human Isoform VEGF165B |
| Activity cross reaction | Reacts with Vascular endothelial growth factor A (VEGF-A) from human |
| Species | Hu |
| Labelling | None |
| Form | Purified (protein A) |
| Preservative | None |
| Storage instructions | Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt. |
| Target | Vascular endothelial growth factor A , Isoform VEGF165b |
| Uniprot ID | P15692-8 |
| Applications | ELISA, IHC, WB |
| Working dilutions | Optimal dilutions should be determined by the end user. The following are guidelines only: - WB : 1/500 to 1/5 000 - IHC : 1/200 to 1/2000 |
| Publication | * Boudria A et al. VEGF165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a β1 integrin/VEGFR autocrine loop. Oncogene. 2018 Sep 7. |
Write Your Own Review